We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+25.96%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
AUM
$91M
AUM Growth
+$8.18M
Cap. Flow
-$8.22M
Cap. Flow %
-9.03%
Top 10 Hldgs %
77.23%
Holding
461
New
74
Increased
130
Reduced
52
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 12.05%
2 Technology 2.45%
3 Financials 1.96%
4 Industrials 1.54%
5 Consumer Discretionary 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
151
AbbVie
ABBV
$454B
$16K 0.02%
+164
New +$14.4K
BAC icon
152
Bank of America
BAC
$436B
$16K 0.02%
657
-88
-12% -$2.08K
DE icon
153
Deere & Co
DE
$169B
$16K 0.02%
105
+1
+1% +$145
KGC icon
154
Kinross Gold
KGC
$28.6B
$16K 0.02%
2,262
SRTY icon
155
ProShares UltraPro Short Russell2000
SRTY
$78.5M
$16K 0.02%
+15
New +$26K
STRM
156
DELISTED
Streamline Health Solutions
STRM
$16K 0.02%
813
SYNA icon
157
Synaptics
SYNA
$4.55B
$16K 0.02%
269
VAPO
158
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$16K 0.02%
41
-147
-78% -$31K
BTI icon
159
British American Tobacco
BTI
$131B
$15K 0.02%
+394
New +$15.1K
DVA icon
160
DaVita
DVA
$15.2B
$15K 0.02%
+186
New +$14.5K
HCAT icon
161
Health Catalyst
HCAT
$159M
$15K 0.02%
+515
New +$14.2K
SYK icon
162
Stryker
SYK
$129B
$15K 0.02%
81
HRTX icon
163
Heron Therapeutics
HRTX
$86.9M
$14K 0.02%
700
TMO icon
164
Thermo Fisher Scientific
TMO
$208B
$14K 0.02%
38
-493
-93% -$165K
DEM icon
165
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.88B
$13K 0.01%
346
+4
+1% +$141
NVS icon
166
Novartis
NVS
$297B
$13K 0.01%
146
+87
+147% +$7.51K
PFG icon
167
Principal Financial Group
PFG
$24B
$13K 0.01%
310
PSX icon
168
Phillips 66
PSX
$83.3B
$13K 0.01%
185
-11
-6% -$779
QCOM icon
169
Qualcomm
QCOM
$179B
$13K 0.01%
141
+105
+292% +$8.42K
SPGI icon
170
S&P Global
SPGI
$130B
$13K 0.01%
38
+12
+46% +$3.61K
TER icon
171
Teradyne
TER
$52.4B
$13K 0.01%
153
VDE icon
172
Vanguard Energy ETF
VDE
$9.87B
$13K 0.01%
+250
New +$12.3K
SRNE
173
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$13K 0.01%
+2,000
New +$7.66K
ALXN
174
DELISTED
Alexion Pharmaceuticals
ALXN
$13K 0.01%
+71
New +$7.54K
PFNX
175
DELISTED
Pfenex Inc.
PFNX
$13K 0.01%
1,589
+839
+112% +$6.28K

Similar funds

HighMark Wealth Management's Q2 2020 Portfolio in Review

As of Q2 2020, HighMark Wealth Management held 461 positions worth $91M, up 9.9% from $82.9M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

HighMark Wealth Management withdrew a net $8.22M in Q2 2020, closing 24 positions and reducing 52 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $104K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.2% a quarter earlier, followed by Technology and Financials.

Against the trend, HighMark Wealth Management opened a new position in Immunomedics Inc worth $2.81M.

  • HighMark Wealth Management's largest Q2 2020 buy was Immunomedics Inc: 79,422 shares worth $2.81M.
  • HighMark Wealth Management added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $407K increase.
  • HighMark Wealth Management's biggest Q2 2020 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $13M.
  • HighMark Wealth Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, selling an estimated $104K.
  • HighMark Wealth Management's ten largest holdings make up 77% of its $91M portfolio in Q2 2020.
  • HighMark Wealth Management opened 74 new positions and closed 24 in Q2 2020.
  • HighMark Wealth Management's portfolio value rose 9.9% quarter-over-quarter to $91M.

Based on HighMark Wealth Management's 13F filing for Q2 2020, filed 22 Jul 2020.